Sort
130,381 grants matching “hiv”
UNC MACS/WIHS Combined Cohort Study Clinical Research Site
$2,808,715Adaora A Adimora · Univ Of North Carolina Chapel Hill · U01 · FY2020 · HL
HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA
$2,808,343Craig R Cohen · University Of California, San Francisco · U62 · FY2007 · PS
Alternative Formulations of Tenofovir and UC781
$2,808,029Sharon L Hillier · Magee-Women'S Res Inst And Foundation · U19 · FY2013 · AI
Engineering T cells to Provide Durable Control of HIV-1 Replication
$2,807,871James L Riley · University Of Pennsylvania · U19 · FY2021 · AI
PS09-962 SUPPORTING THE IMPLEMENTATION AND EZPANSION OF HIGH QUALITY HIV PREV
$2,807,169Christine Galavotti · Care Usa · U2G · FY2015 · PS
Non-Invasive In Vivo Imaging of CD4 pool in HIV-1 Infected Patients
$2,805,297C.k. Osborne · Leidos Biomedical Research, Inc. · N01 · FY2024 · AI
Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders
$2,804,656Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2018 · HL
The University of North Carolina Center for AIDS Research
$2,803,961Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2024 · AI
The University of North Carolina Center for AIDS Research
$2,803,767Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2025 · AI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of HIV Envelope Proteins
$2,803,254Jon Carl Mirsalis · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI
SUPPORT SERVICES OF THE HIV AIDS CLINICAL TRIAL NETWORKS
$2,802,733Barbara Driver · Westat, Inc. · N01 · FY2025 · HD
Award of Part B - In Vitro Testing Resources for AIDS Therapeutics Development
$2,802,585Marintha Heil · Southern Research Institute · N01 · FY2010 · AI
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
$2,801,829Judith S. Currier · University Of California Los Angeles · UM1 · FY2024 · AI
PREVENTION OF HIV INFECTION IN HEALTH CARE SETTINGS IN CAMEROON
$2,800,500Jean Bosco Nfetam Elat · National Aids Control Committee · U2G · FY2012 · PS
Development of Ad26/Env Vaccines for HIV
$2,800,000Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2021 · AI
Expanding Access and Enhancing Quality of Integrated HIV Confidential, Voluntary
$2,800,000Spana Rosinah Motsisi · Tebelopele Voluntary Cnsling/Testing Ctr · U2G · FY2013 · GH
Development of Ad26/Env Vaccines for HIV
$2,800,000Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2018 · AI
SUPPORTING THE SCALE-UP HIGH QUALITY HIV CARE AND TREATMENT PROGRAMS IN MALAWI
$2,800,000Dr. Steve Kamiza · University Of Malawi · U2G · FY2011 · PS
Development of Ad26/Env Vaccines for HIV
$2,799,999Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2020 · AI
Development of Ad26/Env Vaccines for HIV
$2,799,999Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2022 · AI
Development of Ad26/Env Vaccines for HIV
$2,799,999Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2019 · AI
MULTICENTER AIDS COHORT STUDY
$2,799,416John P Phair · Howard Brown Health Center · U01 · FY2006 · AI
Appalachian Node
$2,799,142Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2019 · DA
Centers for AIDS Research (CFAR)
$2,798,920Georgia D Tomaras · Duke University · P30 · FY2023 · AI
SUPPORT THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE AND
$2,798,260Aabid Ahmed · Mkomani Clinic Society · U2G · FY2013 · PS